APA (7th ed.) Citation

Ling Liu, Pengxiang Zhou, Pengxiang Zhou, Zhenhuan Wang, Suodi Zhai, Suodi Zhai, & Wei Zhou. (2022). Efficacy and Safety of Omalizumab for the Treatment of Severe or Poorly Controlled Allergic Diseases in Children: A Systematic Review and Meta-Analysis. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Ling Liu, Pengxiang Zhou, Pengxiang Zhou, Zhenhuan Wang, Suodi Zhai, Suodi Zhai, and Wei Zhou. Efficacy and Safety of Omalizumab for the Treatment of Severe or Poorly Controlled Allergic Diseases in Children: A Systematic Review and Meta-Analysis. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Ling Liu, et al. Efficacy and Safety of Omalizumab for the Treatment of Severe or Poorly Controlled Allergic Diseases in Children: A Systematic Review and Meta-Analysis. Frontiers Media S.A., 2022.